The growing teratoma syndrome:: results of therapy and long-term follow-up of 33 patients

被引:150
作者
André, F
Fizazi, K
Culine, S
Droz, JP
Taupin, P
Lhommé, C
Terrier-Lacombe, MJ
Théodore, C
机构
[1] Inst Gustave Roussy, Dept Med, F-94805 Villejuif, France
[2] Ctr Val Aurelle, Dept Med, Montpellier, France
[3] Ctr Leon Berard, Dept Med, F-69373 Lyon, France
[4] Inst Gustave Roussy, Dept Pathol, Villejuif, France
关键词
chemotherapy; germ cell tumour; growing teratoma syndrome; prognosis; seminoma; surgery; teratoma; testicular neoplasms; ovarian cancer;
D O I
10.1016/S0959-8049(00)00137-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Growing teratoma syndrome (GTS) is defined as an increase in tumour size during or after chemotherapy for germ cell tumour (GCT), and only mature teratoma at histological analysis of the resected tumour specimen. Between 1985 and 1997, 30 male patients fulfilling GTS criteria were included in the present study. 3 female patients were also included but analysed separately. A mature teratoma component was found in 86% of the primary GCT. 3 male patients (10%) had a complication at diagnosis of GTS. One male patient (4%) having undergone complete resection (n = 24) had a recurrent GTS, compared with all but 1 patient (83%) in whom resection was partial (n = 6) (P < 0.001). 2 (8%) and 3 (50%) male patients treated with complete and partial resection subsequently developed a malignant NSGCT respectively (P = 0.01). 2 female patients treated with partial resection presented a recurrent GTS. One of them died of this recurrent CTS. GTS is an entity in its own right with respect to complications and the natural history of the disease. Complete surgical resection is the treatment of choice for GTS. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1389 / 1394
页数:6
相关论文
共 37 条
[1]  
Ahmed F Y, 1996, Clin Oncol (R Coll Radiol), V8, P125, DOI 10.1016/S0936-6555(96)80122-1
[2]  
AHMED T, 1985, CANCER, V56, P860, DOI 10.1002/1097-0142(19850815)56:4<860::AID-CNCR2820560426>3.0.CO
[3]  
2-3
[4]   TREATMENT OF TESTICULAR CANCER AND THE DEVELOPMENT OF SECONDARY MALIGNANCIES [J].
BOKEMEYER, C ;
SCHMOLL, HJ .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (01) :283-292
[5]  
Bontis J., 1996, European Journal of Gynaecological Oncology, V17, P49
[6]  
CASTEDO SMMJ, 1989, CANCER RES, V49, P672
[7]  
CUDENNEC CA, 1981, J EMBRYOL EXP MORPH, V61, P51
[8]  
DELEO MJ, 1988, CANCER, V62, P985, DOI 10.1002/1097-0142(19880901)62:5<985::AID-CNCR2820620524>3.0.CO
[9]  
2-8
[10]  
EINHORN LH, 1996, P AN M AM SOC CLIN, V15, P240